Privacy Policy

1. Introduction

At Tcelltech, we are committed to protecting your personal data and respecting your privacy. This Privacy Policy explains how we collect, use, and protect your information when you visit our website at www.tcelltech.com.

2. Information We Collect

We may collect and process the following types of data:

Personal Identification Information: Name, email address, phone number, company name (only when voluntarily submitted through contact forms or emails).

Technical Data: IP address, browser type, device information, operating system, referring URLs.

Usage Data: Pages visited, time spent on the site, interaction data (via cookies or analytics tools).

3. How We Use Your Data

We use your data to:

We do not sell or rent your personal data to third parties.

4. Cookies

Our website uses cookies to improve functionality and analyze traffic. You can adjust your browser settings to refuse cookies or notify you when cookies are being used.

For more information, please visit our Cookie Policy (link if available).

5. Third-Party Services

We may use trusted third-party tools and providers, such as:

These providers are obligated to comply with relevant data protection regulations.

6. Data Security

We implement appropriate technical and organizational measures to safeguard your personal information against unauthorized access, loss, or alteration.

7. Your Rights (GDPR)

If you are a resident of the European Economic Area (EEA), you have the following rights:

To exercise any of these rights, please contact us at [insert contact email].

8. Data Retention

We retain personal data only for as long as necessary for the purposes set out in this policy, or to comply with legal requirements.

9. Changes to This Policy

We may update this Privacy Policy from time to time. All changes will be posted on this page with an updated effective date.

10. Contact Us

If you have any questions about this Privacy Policy or our data practices, please contact:

Tcelltech
Email: linxiaojuan@tcelltech.com

Gangxiong Huang, MD

Co-founder, CEO

Dr. Huang’s research has focused on tumor metastasis and T-cell immunotherapy. He completed his postdoctoral training and subsequently served as a researcher at The University of Texas MD Anderson Cancer Center. He also served as a pathologist and Minjiang Scholar Professor at Fujian Medical University previously.

Lieping Chen, MD, PhD​

Co-founder, Scientific advisor

Dr. Chen is a pioneer in cancer immunotherapy. His research focuses on fundamental T-cell biology and the translation of scientific discoveries into clinical therapies, with a primary emphasis on cancer immunotherapy. He discovered PD-L1 and established its role in tumor immune evasion, laying the foundation for anti-PD-1/PD-L1 therapies that have transformed cancer treatment worldwide. Among his other numerous discoveries, B7-H3 has emerged as a promising universal therapeutic target for solid tumors. 

Dr. Chen is United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine at Yale University. He held faculty positions at the Mayo Clinic, Johns Hopkins University, and scientist positions in the Bristol-Myers Squibb Co. before joining Yale University. Dr. Chen is a member of the National Academy of Sciences, the National Academy of Medicine, and a Fellow of the American Association for Cancer Research.